BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
1289030
Number of visits today
746
Number of downloads
874488
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Yang A, Liu X, Liu P, Feng Y, Liu H, Gao S, Huo L, Han X, Wang J, Kong W. LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis. Cell Mol Biol Lett 2021;26:33. [PMID: 34238213 DOI: 10.1186/s11658-021-00275-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yin X, Lin H, Lin L, Miao L, He J, Zhuo Z. LncRNAs and CircRNAs in cancer. MedComm 2022;3. [DOI: 10.1002/mco2.141] [Reference Citation Analysis]
2 Zhang S, Jiang M, Cao H, Xiong J, Xu J. CTB-193M12.5 Promotes Hepatocellular Carcinoma Progression via Enhancing NSD1-Mediated WNT10B/Wnt/β-Catenin Signaling Activation. JHC 2022;Volume 9:553-69. [DOI: 10.2147/jhc.s365302] [Reference Citation Analysis]
3 Wo L, Zhang B, You X, Hu Y, Gu Z, Zhang M, Wang Q, Lv Z, Zhao H. Up-regulation of LncRNA UCA1 by TGF-β promotes doxorubicin resistance in breast cancer cells. Immunopharmacol Immunotoxicol 2022;:1-8. [PMID: 35332839 DOI: 10.1080/08923973.2022.2054428] [Reference Citation Analysis]
4 Shao J, Jin Y, Shao C, Fan H, Wang X, Yang G. Serum exosomal pregnancy zone protein as a promising biomarker in inflammatory bowel disease. Cell Mol Biol Lett 2021;26:36. [PMID: 34376139 DOI: 10.1186/s11658-021-00280-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345